Contact UsCompany ProfileHome
Saaskin Technologies
Send Inquiry Send SMS
Mindray Cancer Antigen 15-3 (CLIA) Mindray Cancer Antigen 15-3 (CLIA) Mindray Cancer Antigen 15-3 (CLIA)
Mindray Cancer Antigen 15-3 (CLIA)
Mindray Cancer Antigen 15-3 (CLIA) Mindray Cancer Antigen 15-3 (CLIA)

Mindray Cancer Antigen 15-3 (CLIA)

Product Details:

  • Usage Type Hospital/Clinical Laboratory
  • Accuracy >98%
  • Shelf Life 12 months
  • Storage Instructions 2C8C, protect from light
  • Measurement Range 0.5300 U/mL
  • Display Type N/A (Analyzer based)
  • Features High sensitivity and specificity, ready-to-use reagents
  • Click to View more
X

Mindray Cancer Antigen 15-3 (CLIA) Price And Quantity

Mindray Cancer Antigen 15-3 (CLIA) Product Specifications

  • Standard (As per analyzer specifications)
  • CLIA (Chemiluminescence Immunoassay)
  • N/A (Analyzer based)
  • High sensitivity and specificity, ready-to-use reagents
  • New
  • Low
  • 100-240 V
  • CLIA Reagent Kit
  • N/A (Depends on the analyzer used)
  • Automatic
  • White/Labelled
  • Immunoassay Analyzer Kit
  • Plastic and Chemical Reagents
  • Cancer Marker Detection (Breast Cancer)
  • Detection of Cancer Antigen 15-3 in Human Serum
  • Yes
  • Hospital/Clinical Laboratory
  • >98%
  • N/A (Kit based)
  • No
  • 12 months
  • 2C8C, protect from light
  • No
  • 0.5300 U/mL
  • Electric

Product Description

Brand Mindray

Sample Type Serum

Pack Size 2 x 50T, 2 x 100T

CAT No 10500421600, 10500424300

Application Immuno-Assay

Ourchemiluminescence immunoassay reagentshave been specially developed to work with Mindray's CL series automatic chemiluminescence immunoassay analyzers to make a complete system, offering high reliability and accuracy. Mindray uses liquid, ready-to-use reagents which come in two packages, 50 tests and 100 tests, to suit customers with different requirements.



Advanced CLIA Technology for Cancer Marker Detection

The Mindray CA15-3 CLIA kit leverages sophisticated two-site sandwich chemiluminescence immunoassay technology. Optimized for compatibility with Mindray CL-series analyzers, it enables automated, high-throughput processing essential for modern laboratories. Its high sensitivity ensures the reliable detection of CA15-3 in serum or plasma, aiding clinicians in breast cancer management.


Reliable Performance with Comprehensive Quality Controls

This kit includes both positive and negative controls in each pack, guaranteeing confidence in every batch run. Calibration is straightforward, utilizing a multi-point onboard calibration curve for precise quantification. Ready-to-use, predispensed reagents further reduce hands-on time and minimize procedural errors, enhancing consistency and workflow efficiency.


User-Friendly and Efficient for Clinical Laboratories

Mindray's CA15-3 kit is designed for automatic processing, supporting hospital and clinical laboratories aiming for accurate and timely cancer marker detection. Its low noise operation, easy storage (2-8C, protected from light), and twelve-month shelf life make it practical and dependable. The kit's wide measurement range (0.5-300 U/mL) fits varying patient diagnostics needs.

FAQ's of Mindray Cancer Antigen 15-3 (CLIA):


Q: How does the Mindray Cancer Antigen 15-3 (CLIA) kit detect CA15-3 in patient samples?

A: The kit utilizes a two-site sandwich chemiluminescence immunoassay, where specific antibodies capture and detect Cancer Antigen 15-3 in human serum or plasma. The resulting chemiluminescent signal correlates with the CA15-3 concentration, measured automatically by compatible Mindray CL-series analyzers.

Q: What clinical benefit does CA15-3 testing provide for breast cancer patients?

A: CA15-3 testing aids clinicians in monitoring breast cancer progression, assessing treatment response, and detecting potential recurrence. Its high sensitivity and specificity support informed, real-time clinical decisions to improve patient outcomes.

Q: When and where should the Mindray CA15-3 CLIA kit be used?

A: The kit is intended for use in hospital and clinical laboratories equipped with Mindray CL-series immunoassay analyzers. It is suitable for routine or follow-up testing, whenever breast cancer marker analysis is clinically indicated.

Q: What is the process for performing the CA15-3 test with this kit?

A: The process involves loading serum or plasma samples, predispensed reagents, calibrators, and controls into the analyzer. The instrument automates incubation and measurement based on onboard protocols. Results are delivered quickly via the analyzer interface.

Q: How should the reagents and kit be stored to ensure optimal stability?

A: Store the Mindray CA15-3 kit at 2C-8C, protected from light. Adhering to these storage conditions preserves reagent quality throughout the 12-month shelf life.

Q: What are the key features that enhance the reliability and ease of this test kit?

A: Key features include ready-to-use predispensed reagents, onboard calibration curves, included positive and negative controls, high throughput compatibility, and a broad measurement range. Together, these attributes provide accuracy, consistency, and streamlined laboratory workflow.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Medical Reagents' category



trade india member
SAASKIN CORPORATION PRIVATE LIMITED All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.